Half of Patients Near Death Still Take Potentially Inappropriate Medications
This meta-analysis quantifies polypharmacy and potentially inappropriate medication (PIM) burden in older adults with a prognosis of 6 months or less, and shows how the choice of screening tool changes the measured problem, which matters for pharmacists designing deprescribing triggers.
📅 Journal publication: Oct 31, 2026·Last updated: Nov 16, 2026
Polypharmacy affects 76% of elderly near end-of-life patients.
Polypharmacy and potentially inappropriate medications (PIMs) increase risk in elderly patients with a limited prognosis. Polypharmacy prevalence was 76%, with 54% using PIMs and excessive polypharmacy at 34%. High variability in PIM definitions limits immediate guideline development, but underscores the need for deprescribing protocols. Initiate evidence-based deprescribing in end-of-life care to reduce inappropriate medication use.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Yaw XE, Wong YJ, Cheong WL, Bell JS, Hamzah E, Lee SWH
Citation:Yaw XE, Wong YJ, Cheong WL, et al. Prevalence of polypharmacy and potentially inappropriate prescribing in older adults with a prognosis of 6 months or less: a systematic review and meta-analysis. Age and ageing. 2026;55(11). doi:10.1093/ageing/afag326